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Purpose: To investigate the effect of Manasamitra vatakam (MMV), an Ayurvedic formulation, on 
aluminium (Al)-induced neurotoxicity in rats. 
Methods: Wistar rats were selected for the present study and were divided into four groups of six 
animals each. Group I (control) received tap water while group II received aluminium chloride (AlCl3, 100 
mg/kg/day). Group III was treated with concurrently Al chloride (100 mg/kg/day) and MMV drug (100 
mg/kg /day). Group IV were administered MMV (100 mg/kg/day) for 90 days. Behavioral tests were 
performed on the rats during the experiment. At the end of the experiment various biochemical, 
neurochemical and histopathological histopathological was assessments were also carried out on the 
blood and brain of the rats.  
Results: Following MMV treatment, there was a significant recovery in the performance of the radial 
maze and muscle grip strength of the rats, as well as the levels of deoxyribonucleic acid (DNA), 
ribonucleic acid (RNA), and acetylcholinestrase (AChE) in different parts of the rat’s brain. The 
neuroprotective efficacy of MMV was supported by histopathological observations. Furthermore, MMV 
afforded protection against oxidative damage in the rats. 
Conclusion: MMV prevents Al-induced toxicity in peripheral as well as in central nervous systems of 
rats. Therefore, further studies are required to ascertain its usefulness in humans. 
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INTRODUCTION 
 
Aluminium metal (Al) is ubiquitous in the 
environment and may be linked to some 
diseases such as Alzheimer’s disease, 
dementia and Parkinsonism. The daily intake 
of aluminium is estimated to be 
approximately 10 – 20 mg from cooking 
utensils, food additives and medicines such 
as, antacids or deodorants [1]. Since a 
variety of biomolecules are able to bind 
aluminium, and it can displace other 
biological cations (such as calcium and 
magnesium) from their binding sites, almost 
every metabolic pathway is a potential target 
for the adverse effects of aluminium.  
 
Strong et al [2] reported that Al
3+
 exposure 
cause impairments in glucose utilization, 
agonist-stimulated inositol phosphate 
accumulation. Aluminium salts may bind to 
DNA and RNA, may inhibit the activity of 
enzymes such as hexokinase, alkaline 
phosphatases, and phosphodiesterase [3]. It 
is known to enhance the peroxidative 
damage of lipids and decreases the 
antioxidant status in different parts of the rat 
brain. On the other hand, various natural 
antioxidants have been used as 
neuroprotective drugs which may increase 
the antioxidant status and thus maintain the 
proper functioning of brain, however, the 
detail mechanism of action of these drugs is 
not known. Manasamitra vatakam (MMV) is 
an herbo mineral drug used in India’s 
Ayurvedic system of medicines for treating 
cognitive deficits. We previously reported the 
presence of phytoconstituents such as 
alkaloids, steroids, protein, tannins, phenols, 
flavanoids, saponins, amino acid, glycosides 
in the MMV.  We also observed that MMV 
could affect the synthesis and release of a 
specific neurotransmitter enzyme, acetyl 
cholinesterase [4] as well as influenced 
various antioxidants parameters and showed 
good free radical scavenging activities [4]. 
However, the detailed mechanism of action 
as well as the neuroprotective effect of MMV 
are not yet known. Therefore, the objective of 
this study was to investigate the neuro-
protective effect of MMV against Al-induced 
neurotoxicity and also to determine the 
relationship between molecular changes in 







Aluminium chloride was purchased from 
Merck, Chennai, India. Tritonx-100 solution 
was purchased from Sigma-Aldrich Pvt Ltd., 
Bangalore, India. Standard pellet diet was 
obtained from Hindustan Lever, Bangalore, 
India. All other chemicals were purchased 
from Sisco Research Laboratories Pvt. Ltd, 
India. 
 
Test drug  
 
The Ayurvedic proprietary formulation, 
Manasamitra Vatakam (MMV) was obtained 
from Kotakkal arya vidya sala, Kerala, India. 
It was dissolved in distilled water and used 




Male Wistar albino rats (200 – 220 g) were 
housed in clean polypropylene cages and 
maintained at the room temperature 23 -25
o
C 
with alternate 12 h light and dark cycles. The 
animals were fed on standard pellet diet and 
drinking water ad libitum. All procedures were 
carried out in accordance with the guidelines 
for care and use of laboratory animals. The 
protocols were approved by the institutional 
animal ethical committee (ref no. 
14/18/IAEC/24/07/07) of C.L. Baid Metha 
College of Pharmacy (Chennai, India). 
 
Acute toxicity study 
 
Acute toxicity study was conducted according 
to Organization for Economic Cooperation 
and Development (OECD) guidelines (no. 
423). Three mice (aged 5 – 6 weeks and 
weighing 25 – 30 g) were selected for the 
study. A single high dose of MMV (2,000 
Thirunavukkarasu et al   
Trop J Pharm Res, February2012;11 (1): 77 
mg/kg body weight was given orally to each 
animal. The animals were observed for 1 h 
continuously for any mortality or gross 
behavioral changes, then hourly for 4 h and 
thereafter, after every 24 h for up to 15 days 
[5]. 
 
Experimental design   
 
The rats were divided into four groups of six 
animals each. Group I served as control and 
received the tap water while group II received 
aluminium chloride (100 mg/kg / day) 
dissolved in drinking water. Group III was 
treated simultaneously with aluminium 
chloride (100 mg/kg /day) and MMV (100 
mg/kg). Group IV was administered only 
MMV (100 mg/kg). MMV and aluminium 
chloride (Al) were administered orally for 90 
days except for group I. The animals were 
weighed twice a month and behavioral 
observations were recorded before and at the 
end of the experiment. 
 
Behavioral assessment  
 
Radial arm maze test  
 
Radial maze is used to evaluate working 
memory in animals and cognitive tasks as 
comprehension, learning and reasoning. 
Each arm (50 x 12cm) of the eight arms 
radial maze extends from an octagonally 
shaped central hub of 30 cm diameter. The 
platform remains elevated up to 40 cm above 
the floor and small black plastic cups can be 
mounted at the end of each arm as 
containers for food. The trial is considered 
complete when the rats visit all eight arms or 
spends 10 min in the maze. Entry into an arm 
which the rat had not previously visited is 
recorded as a correct response and re-entry 
is counted as an error. The percentage of 
successful rats was calculated based on the 
total running time divided by the total number 





The effect of aluminium as well as MMV 
treatment on muscle performance was 
evaluated using Rota-rod (Techno) test. All 
the rats were given two initial training trials of 
300 s, approximately 10 min apart, to 
maintain posture on the Rota-rod (3 cm in 
diameter and rotating at a constant 20 
rev/min). After the initial training trials, a 
baseline trial of 120 s was conducted. The 
time each animal remained on the rota-rod 
was recorded. The animals that did not fall off 
the Rota-rod were given a maximum score of 
120 s [6]. 
 
Biochemical assessment  
 
Blood samples were collected from each 
animal by retro-orbital sinus puncture at the 
end of experiment. The blood samples were 
centrifuged at 4000 rpm for 5 min and the 
serum separated was stored at −20 
o
C for 
evaluation of plasma glucose, Alkaline 
phosphatase (ALP), Serum glutamyl-
oxaloacetate transaminase (SGOT), Serum 
glutamyl pyruvate transaminase (SGPT) and 
glucose were assessed using an 
autoanalyser (Biosystem 250).  
 
The rats were sacrificed by cervical 
dislocation, the brain of each rat removed, 
immediately washed well with ice-cold saline 
to remove blood and stored at −80 
o
C 
pending determination of biochemical 
parameters. The hippocampus and cerebral 
cortex were micro-dissected following the 
technique of Paxinos and Watson [7]. The left 
and right cerebral cortex of the brain of one 
rat was pooled to make one sample. A total 
of 10 % homogenate was prepared using 
phosphate buffer (0.1M, pH 7.4) containing 
1mmol ethylene diamine-tetra-acetic acid 
(EDTA), 0.25M sucrose, 10mM potassium 
chloride (KCl) and 1mM phenyl methyl 
sulfonyl fluoride (PMSF) with a Potter-
Elvehijem type homogenizer fitted with a 
teflon plunger, which was centrifuged at 800 
g for 5 min at 4 
o
C in an IEC020 refrigerated 
centrifuge to yield the supernatant. The 
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supernatant were used for the estimation of 
acetyl cholinestrase (AChE). The remaining 
supernatant was again centrifuged at 12,365 
g for 15 min at 4 
o
C to obtain supernatant, 
which was used for the determination of brain 
levels of DNA and RNA. 
 
DNA and RNA assays 
 
Both total tissue DNA and RNA were 
separately extracted and assayed according 
to the method described by Sambrook et al 
[8]. and expressed in mg DNA/g tissue and 
mg RNA/g tissue, respectively.  
 
Evaluation of tissue acetyl cholinesterase 
(AChE) 
 
The acetylcholinesterase activity of rat brain 
tissue was determined by the method of 
Ellman et al [8]. An aliquot of the brain 
homogenate (0.4 ml obtained earlier was 
added to a cuvette containing 2.6 ml of 
phosphate buffer (pH 8.0, 0.1M), 100 µl of 2,4 
dithionitrobenzene (DTNB) reagent was 
added to the cuvette  followed by the addition 
of 20 µl of acetylthiocholine iodide (AChI). 
Thiocholine reacted with DTNB reagent to 
produce a yellow color which was read 
spectrophotometrically at 412 nm.  
 
Histopathological studies   
 
Histopathological evaluation was performed 
by the method of Nakayama et al [10]. The 
brain hippocampus of each animal was fixed 
with 10 % formalin and further embedded in 
paraffin with wax. The blocks were processed 
for sectioning; the sections were then stained 
with haematoxylin and eosin as nuclear and 
cytoplasmic stains, respectively. Pathological 
changes, if any, were viewed under light 




Statistical analysis was carried out using 
Graph Pad Prism software (version 4.03). 
One-way ANOVA was applied to process the 
data, followed by Newman-Keuls multiple 
comparison test. The data are presented as 
mean ± SEM. The level of statistical 




Effect of Al chloride on mice behavioral 
characteristics   
 
When the mice were treated with MMV up to 
2000 mg/kg p.o. there was neither mortality 
nor any sign of gross behavioral changes 
after 48 h, and 15 days. However, it was 
observed that the numbers of entries into 
radial arms of the rats increased in Al-treated 
rats, and the animals also spent less time in 
each radial arm of the apparatus, compared 
with the normal control. On the other hand, in 
groups III and IV the behavioural 
characteristics of learning and reasoning 
increased (Figure 1). 
 
 
Figure 1: Effect of MMV on behavioural 
characteristics (mean ± SEM), assessed by Rota 
rod and Radial Maze analysis; 
a 
p < 0.001, AlCl3 
group compared with control group; 
b
 p < 0.001, 
MMV+AlCl3 group compared with aluminium-
treated group;  
c
 not significant (p < 0.001), MMV-
treated group compared with control    
 
A significant decrease (p < 0.001) in muscle 
strength and locomotor activities was 
observed in Al-exposed rats compared with 
normal control. On the other hand, significant 
improvement in the muscle strength and 
muscle grip occurred in MMV-treated rats 
compared with Al-treated rats (Figure 1).                               
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Biochemical parameters 
 
Figure 2 shows the effect of MMV on plasma 
parameters. Oral administration of Al (100 mg 
/kg) for 90 days significantly (p < 0.001) 
increased plasma glucose, ALP, SGOT and 
SGPT whereas co-administration of MMV 
with Al significantly (p < 0.001) decreased the 
levels of these parameters in rats. There was 
no significant alteration in plasma glucose, 
ALP, SGOT and SGPT when compared with 





Figure 2: Effect of MMV on biochemical 
parameters (mean ± SEM) in Al- treated rats.  
a 
p ≤ 0.001,AlCl3 group compared with control 
group; 
b
 p ≤ 0.001, MMV+AlCl3 group compared 
with aluminium-treated group;  
c
  not significant (p 
≤ 0.001) MMV treated group versus control  
 
The effect of MMV on DNA and RNA levels in 
blood and brain tissues are shown in Figures 
3 and 4.  DNA and RNA significantly 
decreased in Al-treated rats compared with 
normal control (p ≤ 0.001) but increased 
significantly in MMV + Al-treated rats (p ≤ 
0.001) when compared with the Al-treated 
group. On the other hand, there was no 
significant (p ≤ 0.001) alteration of DNA and 
RNA levels in rats treated with MMV alone. 
   
The level of acetyl cholinesterase decreased 
significantly (p ≤ 0.001) in the plasma, brain, 
cerebral cortex and hippocampus of Al-
treated rats (Figure 5). However, the enzyme 
level increased following co-administration of 
MMV and AlCl3 (p ≤ 0.001). 
                                  
 
Figure 3: Effect of MMV on DNA content (mean ± 
SEM) in of plasma, cerebral cortex and 
hippocampus of Al- treated rats. 
a 
p ≤ 0.001,AlCl3 
group compared with control group; 
b
 p ≤ 0.001, 
MMV+AlCl3 group compared with aluminium-
treated group;  
c
  not significant (p ≤ 0.001) MMV 
treated group versus control  
.
 
Figure 4: Effect of MMV on RNA contents (mean 
± SEM) of cerebral cortex and hippocampus of Al-  
treated rats. 
a 
p ≤ 0.001,AlCl3 group compared with 
control group; 
b
 p ≤ 0.001, MMV+AlCl3 group 
compared with aluminium-treated group;  
c
  not 





We observed normal cellular structure of 
hippocampus in normal control group which 
signifies normal working memory of the rats 
(Figure 6A). Gross histopathological 
changes, including heavy loss of cortical 
neurons, lacunae spaces (50 µm diameter), 
ghost cells and vacuolated cytoplasm were 
observed in Al-treated animals (Figure 6B). 
On the other hand, remarkable improvement 
was observed in the MMV + Al-treated group. 
(Figure 6C, D). 
Thirunavukkarasu et al   
Trop J Pharm Res, February2012;11 (1): 80 
 
Figure 5: Acetyl cholinesterase (AChE) level 
(mean ± SEM) in the plasma and brain of MMV t-
treated and Al- exposed rats.
  a
p ≤ 0.001, by 
Newman-Keuls multiple comparison test; AlCl3 (A) 
group was compared with control group; 
b
 p ≤  
0.001, by Newman-Keuls multiple comparison test; 
MMV+AlCl3 group was compared with aluminium-
treated group;  c  - non-significant (ns) control vs 





Figure 6: Microphotographs showing 
histopathological alterations in the hippocampus 
region of (A) control group, (B) Al-treated group 
(100 mg/kg), (C) Al-treated (100 mg/kg) + MMV 





The animals treated with Al revealed altered 
behavioral changes within 90 days, 
suggesting a link between chronic Al-induced 
toxicity and the parameters evaluated. There 
was long-term memory impaired performance 
under the influence of Al exposure. The 
animals spent a shorter time in the arms of 
the test apparatus after exposure to Al, thus 
depicting increased anxiety levels [11]. Re-
entry frequency of the animals increased, 
indicating disturbed cognitive behavior. This 
observation was also supported by 
histopathological findings in that Al treatment 
caused marked alterations such as heavy 
loss of cortical neurons, lacunae spaces (50 
µm diameter), ghost cells and vacuolated 
cytoplasm. On the other hand, animals 
treated with MMV significantly showed 
improvement in cognitive function and long-
term memory. 
 
Following Al exposure, MMV treatment 
facilitated easy identification of previously 
visited arms and this may be due to 
correction in cholinergic neurotransmission, 
which in turn can be linked to altered memory 
function. Bhalla et al [12] reported the 
mechanism of action of Al induced toxicity 
and indicated that it causes defect in 
cognitive function. Levesque et al [13] 
observed severely damaged glia cells in rat 
brain following Al treatment. Hippocampus 
and cerebral cortex are the key structures of 
memory formation. Since the hippocampus is 
especially indispensable in the integration of 
spatial information, a decline in learning 
ability may be induced by the deterioration of 
hippocampal function [23]. 
 
Hu et al [14] has reported that Al-associated 
toxicity diminished motor activities and grip 
strength.  Thus, improvement in a 
neurotransmitter enzyme such as AChE, and 
nuclear materials in rat blood and brain could 
be responsible for the improvement in 
learning, memory, cognition and locomotor 
functions. The importance of neurobehavioral 
studies in risk assessment lies in the fact that 
behavior can be regarded as the net output of 
the sensory, motor and cognitive functions 
occurring in the nervous system and can 
serve as potentially sensitive end-points of 
chemically-induced neurotoxicity. 
The increasing preparation and storage of 
food in Al vessels, cans, and foils may 
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increase the Al content, particularly in food 
that are salty, acidic, or alkaline. There has 
been insufficient concern about toxic 
consequences of Al ingestion because its 
bioavailability was considered to be poor and 
the gastrointestinal tract normally 
represented a barrier to Al absorption under 
normal circumstances but this barrier can be 
breached. It has been shown that individuals 
ingesting large amounts of Al compounds do 
absorb significant amounts resulting in 
elevated plasma levels [15]. 
 
Al-exposed rats showed increased blood 
glucose level which may be due to decreased 
pyruate formation that affects the synthesis of 
acetylcholine. It appears that Al toxic 
potency, which leads to alteration in 
acetylcholine level, might have caused 
neurobehavioral changes. Davis [16] has 
observed that acetyl choline affects human 
memory and cognitive function by 
dramatically decreasing the activity of 
acetylcholine tranferase in the cortex and 
hippocampus of Alzheimer patients. 
 
Increase in blood glucose level may have 
disrupted carbohydrate metabolism due to 
enhanced breakdown of liver glycogen, 
possibly mediated by increase in 
adrenocorticotrophic and glucagon hormones 
and/or reduced insulin activity [17]. Sallam et 
al [18] reported that Al accumulation in the 
liver leads to liver damage as a result of 
increased enzymes levels of ALP, SGOT, 
SGPT and glucose in the serum. Increased 
enzyme levels may cause cellular 
degeneration or destruction of hepatic cells. 
Decreased plasma concentration of ALP, 
SGOT, SGPT and glucose levels in MMV-
treated animals suggests that the drug 
exhibits hepato-protective activity.    
Aluminium is a trivalent cation and has high 
affinity for negatively charged groups such as 
phosphates which are present in nucleic 
acids and phospharelated proteins. Although 
plasma and brain tissue DNA and RNA levels 
of Al-exposed rats decreased, MMV-treated 
rats had these levels restored, thereby 
showing a positive influence of the plant 
extract on either degradation or synthesis of 
nucleic acids in these animals.   
 
Al causes disturbances in cholinergic 
neurotransmission and disrupts the cognitive 
behavior of animals by increasing the stress 
levels. Studies have shown that Al exposure 
results in a decrease in hexokinase activity 
[19], which in turn decreases the pyruvate 
formation and hence affect the synthesis of 
acetylcholine and subsequently the enzyme 
activity of AChE. Kowall et al [20] found that 
Al is a pro-oxidant and indirectly results in the 
production of free radicals leading to 
oxidative damage and reduced levels of 
reactive oxygen species (ROS) which 
indirectly affects acetyl cholinesterase 
enzyme activity.  
 
In our earlier study, increased peroxidative 
damage of lipids and proteins in cells was 
observed after Al exposure in rats [21]. On 
the other hand, MMV-treated rats decreased 
LPO level after drug treatment suggesting 
that MMV can protect against peroxidative 
damage. Since oxidative damage is mediated 
by free radicals, it was necessary to 
investigate the status of endogenous 
antioxidant enzymes under the different 
treatment conditions. The results revealed 
that tissue damage was prevented by MMV 
and this may be due to the presence of active 
molecules such as saponin and flavanoids [4] 
which are well known antioxidants.   
 
An enzyme, such as SOD, is an important 
antioxidant, which protects the brain from 
peroxidase- mediated neuronal damage, and 
therefore, decreased level of these 
biomolecules, may lead to increased severity 
of Al toxicosis in the brain. It was observed 
that in Al intoxication, the activity of 
antioxidant enzyme such as SOD was 
significantly increased compared to control. 
Usually, decreased antioxidant to oxidant 
ratio plays a crucial role in generating a 
condition of oxidative stress. The decreased 
activity might have resulted from oxidative 
modification of proteins. Our previous study 
showed significantly decreased activity of 
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SOD in MMV + Al-treated group; therefore, in 
this experimental condition, SOD may be 
responsible for preventing the tissues from 
oxidative damage [21]. Evidence for stronger 
glia activation has been observed in Al-
exposed animals and this is claimed to be 
responsible for pathological and inflammatory 
events [23]. Inflammatory responses are 
known to play an important role in 
neurodegenerative disease such as 
Alzheimer’s disease (AD). 
 
Gross disruption in brain cells was seen 
during microscopical examination following Al 
treatments, which indicate adverse effects at 
sub-cellular levels including changes in the 
structure of the cerebral cortex due to loss of 
neurons, ghost cells and gliosis.  Struys-
Ponsar et al [22] also found that Al causes 
structural changes in the cerebral cortex due 
to loss of neurons, ghost cells, gliosis, 
hippocampus and cortex, and this may affect 
the various enzymes responsible for 





MMV has a protective effect on the levels of 
various biochemical and neurochemical 
parameters in blood and brain. It can also 
protect against cognitive impairment during 
chemically-induced stress conditions caused 
by metals such as aluminium chloride. Thus, 
MMV is promising for the treatment of 
cognitive impairment in neurodegenerative 
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